Literature DB >> 6802879

Effect of height and weight on the in vivo recovery of transfused factor VIII C.

A Aronstam, D S McLellan, M Wassef, P S Mbatha.   

Abstract

The in vivo recovery of factor VIII has been estimated on 84 occasions in 53 severely affected adolescent haemophiliacs. There was wide individual variation in recovery, which was not affected by differences in the administered dose. Recovery increased steadily with increasing surface area, and it was only over a surface area of 1.7 m2 that a recovery of 2% of factor VIII per unit per kg became the norm. It is suggested that the only safe assumption to make below that surface area in an in vivo recovery of 1.5%.

Mesh:

Substances:

Year:  1982        PMID: 6802879      PMCID: PMC497531          DOI: 10.1136/jcp.35.3.289

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  The laboratory assessment of the efficacy of antihaemophilic therapy.

Authors:  A Lurie
Journal:  S Afr Med J       Date:  1972-06-17

2.  The management of haemophilia.

Authors:  C R Rizza
Journal:  Practitioner       Date:  1970-06

3.  Double-blind controlled trial of three dosage regimens in treatment of haemarthroses in haemophilia A.

Authors:  A Aronstam; M Wasssef; D P Choudhury; P M Turk; D S McLellan
Journal:  Lancet       Date:  1980-01-26       Impact factor: 79.321

4.  My student elective. Problems in Peru.

Authors:  P W Woodruff
Journal:  Br Med J       Date:  1980-01-05
  4 in total
  6 in total

1.  Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.

Authors:  Margaret V Ragni
Journal:  Blood Adv       Date:  2017-04-25

Review 2.  Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.

Authors:  S Björkman; E Berntorp
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Progress of in vitro factor VIII coagulant activity from 0 to 8 hours after reconstitution.

Authors:  Ye Jee Shim; Kun Soo Lee; Uk Hyun Kim; Jin Kyung Suh; Sae Yun Baik; Shin Young Hyun
Journal:  Blood Res       Date:  2014-12-23

4.  Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring.

Authors:  S Björkman; V S Blanchette; K Fischer; M Oh; G Spotts; P Schroth; S Fritsch; L Patrone; B M Ewenstein; P W Collins
Journal:  J Thromb Haemost       Date:  2010-04       Impact factor: 5.824

5.  Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studies.

Authors:  S Björkman; M Carlsson; E Berntorp; P Stenberg
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

6.  Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years: a population analysis based on 50 patients with long-term prophylactic treatment for haemophilia A.

Authors:  Sven Björkman; Anna Folkesson; Siv Jönsson
Journal:  Eur J Clin Pharmacol       Date:  2009-06-26       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.